Exploring the utility of a novel point-of-care whole blood thrombin generation assay following trauma: A pilot study.

Res Pract Thromb Haemost · 2021 · PMC8035795 · PMID 33870025

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP = .05actually significant

Trauma patients on antiplatelet medications also had a significantly decreased ETP (nM × minute) as compared to those not on those medications with the plasma assay (1383 [IQR, 1222‐1549] vs 1241 [IQR, 1103‐1358]; P = .03), but this difference did not reach statistical significance in the whole blood assay (816.3 [IQR, 714.4‐899.9] vs 687.6 [IQR, 617.9‐732.1]; P = .05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.